Campbell & CO Investment Adviser LLC Siga Technologies Inc Transaction History

Campbell & CO Investment Adviser LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$6.32 - $10.46 $944,776 - $1.56 Million	-149,490 Reduced 84.37%	27,686 $210,000
Q1 2024 May 10, 2024	SELL	$4.51 - $8.92 $188,414 - $372,650	-41,777 Reduced 19.08%	177,176 $1.52 Million
Q4 2023 Feb 13, 2024	BUY	$4.82 - $6.25 $864,650 - $1.12 Million	179,388 Added 453.4%	218,953 $1.23 Million
Q3 2023 Nov 08, 2023	BUY	$4.32 - $5.77 $170,920 - $228,290	39,565 New	39,565 $207,000
Q1 2023 May 11, 2023	BUY	$5.23 - $8.42 $105,891 - $170,479	20,247 New	20,247 $116,000
Q2 2022 Aug 09, 2022	BUY	$6.5 - $13.68 $67,463 - $141,984	10,379 Added 44.36%	33,778 $391,000
Q1 2022 May 09, 2022	BUY	$5.96 - $7.61 $11,318 - $14,451	1,899 Added 8.83%	23,399 $166,000
Q4 2021 Feb 10, 2022	SELL	$6.96 - $9.26 $510,864 - $679,684	-73,400 Reduced 77.34%	21,500 $162,000
Q3 2021 Nov 10, 2021	BUY	$5.71 - $7.39 $305,485 - $395,365	53,500 Added 129.23%	94,900 $701,000
Q2 2021 Aug 11, 2021	BUY	$6.1 - $7.58 $252,539 - $313,812	41,400 New	41,400 $260,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $432M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.